Current Wastewater Treatment Sludge Sampling and Analysis Sample Clauses

Current Wastewater Treatment Sludge Sampling and Analysis. In response to discussions with the EPA regarding the implementation of this F006 sludge recycling project, IBM collected samples of the sludge generated at the B/690 F/HM Wastewater Treatment Facility for analysis of appropriate Appendix VIII constituents. In order to develop a comprehensive list of applicable Appendix VIII constituents that would be analyzed as part of an evaluation of F006 sludge for recycling, the following was undertaken. First, IBM began with the full list of Appendix VIII chemical constituents. All chemical constituents for which the F006 sludge is listed were identified as a subset of that list. Next, as discussed previously, a comprehensive review of chemicals used in the manufacturing area which generate wastewater that is conveyed to the F/HM wastewater treatment facilities was conducted. In addition, Appendix VIII constituents associated with wastewater treatment operations were identified. Lastly, specific constituents requested by the EPA were identified including dioxins, furans, high volatile metals, low volatile metals and semivolatile metals were added. Accordingly, Table 2-5 presents a summary of the Appendix VIII constituents of concern along with the appropriate method of analysis. IBM collected samples of the sludge generated at ♦ 1506/FPAFINAL.DOC 2-11 TABLE 2-5 INTERNATIONAL BUSINESS MACHINES CORPORATION EAST FISHKILL FACILITY SUMMARY OF APPLICABLE AND APPROPRIATE APPENDIX VIII CHEMICAL CONSTITUENTS OF CONCERN Constituent Rationale Method of Analysis Cadmium Listed Constituent ICP, Method 6010 or A.A.-Direct Aspiration Method 7130, SW-846 Hexavalent Chromium Listed Constituent, utilized in manufacturing process Colorimetric, Method 7196, SW-846 Nickel Listed Constituent, utilized in manufacturing process ICP, Method 6010 or A.A.-Direct Aspiration Method 7520, SW-846 Cyanide (complexed) Listed Constituent Total and Amendable Cyanide Method 9012, SW-846 Volatile Organic Compounds Chemicals utilized in manufacturing process Volatile Organic Compounds by GC/MS Method 8260, SW-846 Semivolatile Organic Compounds Chemicals utilized in manufacturing process Semivolatile Organic Compounds by GC/MS Method 8270, SW-846 Arsenic Requested by USEPA ICP, Method 6010 or A.A.-Furnace Technique, Method 7060, SW-846 Beryllium Requested by USEPA ICP, Method 6010 or A.A.-Direct Aspiration Method 7090, SW-846 Cadmium Requested by USEPA ICP, Method 6010 or A.A.-Direct Aspiration Method 7130, SW-846 Chromium Utilized in manufacturing proce...
AutoNDA by SimpleDocs

Related to Current Wastewater Treatment Sludge Sampling and Analysis

  • Statistical Sampling Documentation a. A copy of the printout of the random numbers generated by the “Random Numbers” function of the statistical sampling software used by the IRO.

  • First sampling In the first sampling four lamps are selected at random. The first sample of two is marked A, the second sample of two is marked B.

  • Data Analysis In the meeting, the analysis that has led the College President to conclude that a reduction- in-force in the FSA at that College may be necessary will be shared. The analysis will include but is not limited to the following: ● Relationship of the FSA to the mission, vision, values, and strategic plan of the College and district ● External requirement for the services provided by the FSA such as accreditation or intergovernmental agreements ● Annual instructional load (as applicable) ● Percentage of annual instructional load taught by Residential Faculty (as applicable) ● Fall Full-Time Student Equivalent (FFTE) inclusive of dual enrollment ● Number of Residential Faculty teaching/working in the FSA ● Number of Residential Faculty whose primary FSA is the FSA being analyzed ● Revenue trends over five years for the FSA including but not limited to tuition and fees ● Expenditure trends over five years for the FSA including but not limited to personnel and capital ● Account balances for any fees accounts within the FSA ● Cost/benefit analysis of reducing all non-Residential Faculty plus one Residential Faculty within the FSA ● An explanation of the problem that reducing the number of faculty in the FSA would solve ● The list of potential Residential Faculty that are at risk of layoff as determined by the Vice Chancellor of Human Resources ● Other relevant information, as requested

  • Prescription Safety Glasses Prescription safety glasses will be furnished by the employer. The employer retains the authority to establish reasonable rules and procedures regarding frequency of issue, replacement of damaged glasses, limits on reimbursement costs and coordination with the employer's vision plan.

  • Musculoskeletal Injury Prevention and Control (a) The Hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

  • GARBAGE DISPOSAL, RECYCLING, AND BIODEGRADABLE MATERIALS A. Concessionaire shall be responsible for maintaining the cleanliness of the Concession Premises. Concessionaire shall ensure placement of all garbage and trash generated by the Concession Operation in designated containers and that said containers are emptied daily, or as more frequently required by Department, at a location within the Area designated by Department. Disposal costs from this latter location shall be borne by Department. Concessionaire shall provide such additional trash containers as may be required to keep the immediate Concession Premises clean at all times. The type of trash containers provided by Concessionaire shall be approved by Department prior to use.

  • SERVICE MONITORING, ANALYSES AND ORACLE SOFTWARE 11.1 We continuously monitor the Services to facilitate Oracle’s operation of the Services; to help resolve Your service requests; to detect and address threats to the functionality, security, integrity, and availability of the Services as well as any content, data, or applications in the Services; and to detect and address illegal acts or violations of the Acceptable Use Policy. Oracle monitoring tools do not collect or store any of Your Content residing in the Services, except as needed for such purposes. Oracle does not monitor, and does not address issues with, non-Oracle software provided by You or any of Your Users that is stored in, or run on or through, the Services. Information collected by Oracle monitoring tools (excluding Your Content) may also be used to assist in managing Oracle’s product and service portfolio, to help Oracle address deficiencies in its product and service offerings, and for license management purposes.

  • Statistical Analysis 31 F-tests and t-tests will be used to analyze OV and Quality Acceptance data. The F-test is a 32 comparison of variances to determine if the OV and Quality Acceptance population variances 33 are equal. The t-test is a comparison of means to determine if the OV and Quality Acceptance 34 population means are equal. In addition to these two types of analyses, independent verification 35 and observation verification will also be used to validate the Quality Acceptance test results.

  • Indoor Air Quality The Employer shall ensure a healthful air quality and attempt to ensure comfortable air temperature in buildings it owns and in space that it leases.

  • Consent to Transportation and Medical Treatment I consent to the use of first aid treatment and the use of generic and over-the-counter medications and treatments as directed by manufacturer labels, whether administered by the Released Parties or first aid personnel. In an emergency, I understand the Released Parties may try to contact the individual listed below as an emergency contact. If an emergency contact cannot be reached promptly, I hereby authorize the Released Parties to act as an agent for me to consent to any examination, testing, x-rays, medical, dental or surgical treatment for me as advised by a physician, dentist or other health care provider. This includes, but is not limited to, my assessment, evaluation, medical care and treatment, anesthesia, hospitalization, or other health care treatment or procedure as advised by a physician, dentist or other health care provider. I also authorize the Released Parties to arrange for transportation of me as deemed necessary and appropriate in their discretion. I, the Volunteer, do hereby release, forever discharge and hold harmless the Released Parties from any liability, claim, demand, and action whatsoever brought by me or on my behalf which arises or may hereafter arise on account of any transportation, first aid, assessment, care, treatment, response or service rendered in connection with my Activities with any of the Released Parties. If the Volunteer is less than 18 years of age, the parent(s) having legal custody and/or the legal guardian(s) of the Volunteer also hereby release, forever discharge and hold harmless the Released Parties from any liability, claim, demand and action whatsoever brought by such volunteer or on his/her behalf which arises or may hereafter arise on account of the decision by any representative or agent of the Released Parties to exercise the power to transport, administer first aid, and consent to assessment, examination, x-rays, medical, dental, surgical or other such health care treatment as set forth in the Parental Authorization for Treatment of, and Travel With, a Minor Child.

Time is Money Join Law Insider Premium to draft better contracts faster.